Subclinical carotid atherosclerosis: short-term natural history of lipid-rich necrotic core--a multicenter study with MR imaging.
暂无分享,去创建一个
Chun Yuan | Niranjan Balu | Xihai Zhao | Dongxiang Xu | Li Dong | Jie Sun | Daniel S Hippe | Feiyu Li | Thomas S Hatsukami | C. Yuan | T. Hatsukami | D. Hippe | N. Balu | Xihai Zhao | Li Dong | Jie Sun | Dongxiang Xu | Yunjing Xue | Yunjing Xue | Fei-yu Li
[1] M. Robson,et al. Early changes in arterial structure and function following statin initiation: Quantification by magnetic resonance imaging , 2008, Atherosclerosis.
[2] Milind Y Desai,et al. Statin-Induced Cholesterol Lowering and Plaque Regression After 6 Months of Magnetic Resonance Imaging–Monitored Therapy , 2004, Circulation.
[3] Akiko Maehara,et al. A prospective natural-history study of coronary atherosclerosis. , 2011, The New England journal of medicine.
[4] C. Yuan,et al. Arterial remodeling in [corrected] subclinical carotid artery disease. , 2009, JACC. Cardiovascular imaging.
[5] Stephen J. Nicholls,et al. Intravascular ultrasound-derived measures of coronary atherosclerotic plaque burden and clinical outcome. , 2010, Journal of the American College of Cardiology.
[6] C. Yuan,et al. Rationale and Design of the Carotid Plaque in Human for All Evaluations With Aggressive Rosuvastatin Therapy (CHALLENGER Trial) , 2009 .
[7] W. Niessen,et al. Carotid Atherosclerotic Plaque Progression and Change in Plaque Composition Over Time: A 5-Year Follow-Up Study Using Serial CT Angiography , 2012, American Journal of Neuroradiology.
[8] Christopher P Cannon,et al. Intensive versus moderate lipid lowering with statins after acute coronary syndromes. , 2004, The New England journal of medicine.
[9] C. Yuan,et al. MR imaging of carotid plaque composition during lipid-lowering therapy a prospective assessment of effect and time course. , 2011, JACC. Cardiovascular imaging.
[10] R. Cury,et al. Intra‐ and interreader reproducibility of magnetic resonance imaging for quantifying the lipid‐rich necrotic core is improved with gadolinium contrast enhancement , 2006, Journal of magnetic resonance imaging : JMRI.
[11] Aad van der Lugt,et al. Determinants of magnetic resonance imaging detected carotid plaque components: the Rotterdam Study. , 2012, European heart journal.
[12] Chun Yuan,et al. Effect of rosuvastatin therapy on carotid plaque morphology and composition in moderately hypercholesterolemic patients: a high-resolution magnetic resonance imaging trial. , 2008, American heart journal.
[13] W. Kerwin,et al. Contrast‐enhanced high resolution MRI for atherosclerotic carotid artery tissue characterization , 2002, Journal of magnetic resonance imaging : JMRI.
[14] Bruce R. Brodie,et al. Effect of Intensive Compared With Moderate Lipid-Lowering Therapy on Progression of Coronary Atherosclerosis A Randomized Controlled Trial , 2004 .
[15] W. Kerwin,et al. Sample size calculation for clinical trials using magnetic resonance imaging for the quantitative assessment of carotid atherosclerosis. , 2005, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.
[16] Frits Mastik,et al. Effects of the Direct Lipoprotein-Associated Phospholipase A2 Inhibitor Darapladib on Human Coronary Atherosclerotic Plaque , 2008, Circulation.
[17] Raimund Erbel,et al. Spectrum of remodeling behavior observed with serial long-term (>/=12 months) follow-up intravascular ultrasound studies in left main coronary arteries. , 2004, The American journal of cardiology.
[18] P. Neuvonen,et al. Drug interactions with lipid‐lowering drugs: Mechanisms and clinical relevance , 2006, Clinical pharmacology and therapeutics.
[19] Chun Yuan,et al. Presence of Intraplaque Hemorrhage Stimulates Progression of Carotid Atherosclerotic Plaques: A High-Resolution Magnetic Resonance Imaging Study , 2005, Circulation.
[20] Peter J. Kirkpatrick,et al. MRI-derived measurements of fibrous-cap and lipid-core thickness: the potential for identifying vulnerable carotid plaques in vivo , 2004, Neuroradiology.
[21] R. Balaban,et al. Carotid artery atherosclerosis: in vivo morphologic characterization with gadolinium-enhanced double-oblique MR imaging initial results. , 2002, Radiology.
[22] Fei Liu,et al. Magnetic Resonance Imaging of Carotid Atherosclerosis: Plaque Analysis , 2007, Topics in magnetic resonance imaging : TMRI.
[23] C. Yuan,et al. Quantitative Evaluation of Carotid Plaque Composition by In Vivo MRI , 2004, Arteriosclerosis, thrombosis, and vascular biology.
[24] C. Yuan,et al. Sustained acceleration in carotid atherosclerotic plaque progression with intraplaque hemorrhage: a long-term time course study. , 2012, JACC. Cardiovascular imaging.
[25] David Saloner,et al. Atherosclerotic plaque progression in carotid arteries: monitoring with high-spatial-resolution MR imaging--multicenter trial. , 2009, Radiology.
[26] R. Kronmal,et al. Risk Factor Associations With the Presence of a Lipid Core in Carotid Plaque of Asymptomatic Individuals Using High-Resolution MRI: The Multi-Ethnic Study of Atherosclerosis (MESA) , 2008, Stroke.
[27] Chun Yuan,et al. In vivo accuracy of multispectral magnetic resonance imaging for identifying lipid-rich necrotic cores and intraplaque hemorrhage in advanced human carotid plaques. , 2002 .
[28] P. Serruys,et al. First-in-man prospective evaluation of temporal changes in coronary plaque composition by in vivo intravascular ultrasound radiofrequency data analysis: an Integrated Biomarker and Imaging Study (IBIS) substudy. , 2005, EuroIntervention.
[29] Z. Fayad,et al. Effect of lipid-lowering therapy with atorvastatin on atherosclerotic aortic plaques detected by noninvasive magnetic resonance imaging. , 2005, Journal of the American College of Cardiology.
[30] V. Fuster,et al. Effects of aggressive versus conventional lipid-lowering therapy by simvastatin on human atherosclerotic lesions: a prospective, randomized, double-blind trial with high-resolution magnetic resonance imaging. , 2005, Journal of the American College of Cardiology.
[31] V. Fuster,et al. Effects of Lipid-Lowering by Simvastatin on Human Atherosclerotic Lesions: A Longitudinal Study by High-Resolution, Noninvasive Magnetic Resonance Imaging , 2001, Circulation.
[32] M. Budoff,et al. The association of Framingham and Reynolds risk scores with incidence and progression of coronary artery calcification in MESA (Multi-Ethnic Study of Atherosclerosis). , 2010, Journal of the American College of Cardiology.
[33] Chun Yuan,et al. In Vivo Quantitative Measurement of Intact Fibrous Cap and Lipid-Rich Necrotic Core Size in Atherosclerotic Carotid Plaque: Comparison of High-Resolution, Contrast-Enhanced Magnetic Resonance Imaging and Histology , 2005, Circulation.
[34] Ahmed Tawakol,et al. Safety and efficacy of dalcetrapib on atherosclerotic disease using novel non-invasive multimodality imaging (dal-PLAQUE): a randomised clinical trial , 2011, The Lancet.
[35] V. Fuster,et al. Magnetic resonance images lipid, fibrous, calcified, hemorrhagic, and thrombotic components of human atherosclerosis in vivo. , 1996, Circulation.
[36] C. Yuan,et al. Scan‐rescan reproducibility of carotid atherosclerotic plaque morphology and tissue composition measurements using multicontrast MRI at 3T , 2010, Journal of magnetic resonance imaging : JMRI.
[37] V. Fuster,et al. Lipid Lowering by Simvastatin Induces Regression of Human Atherosclerotic Lesions: Two Years’ Follow-Up by High-Resolution Noninvasive Magnetic Resonance Imaging , 2002, Circulation.
[38] M. Robson,et al. Effects of high-dose modified-release nicotinic acid on atherosclerosis and vascular function: a randomized, placebo-controlled, magnetic resonance imaging study. , 2009, Journal of the American College of Cardiology.
[39] C. Zarins,et al. Compensatory enlargement of human atherosclerotic coronary arteries. , 1987, The New England journal of medicine.